Risk Factor Control May Modify Link Between HIV Status and Heart Disease

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 22, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, Jan. 22, 2024 -- Control of dyslipidemia and diabetes, but not hypertension, reduces the association of HIV status with cardiovascular disease (CVD), according to a study published online Jan. 16 in Clinical Infectious Diseases.

Michael J. Silverberg, Ph.D., M.P.H., from Kaiser Permanente Northern California in Oakland, and colleagues conducted a retrospective cohort study involving 8,285 people with HIV (PWH) and 170,517 people without HIV (PWoH) from an integrated health system. Control of risk factors, including hypertension, dyslipidemia, diabetes, and other modifiable factors, was measured using a novel disease management index (DMI), accounting for amount/duration above treatment goals (0 to 100 percent [perfect control]).

The researchers found that PWH and PWoH had similar DMIs (80 to 100 percent) apart from triglycerides, which was worse for PWH, and hemoglobin A1c, which was better for PWH. Compared with PWoH, PWH had an increased risk for CVD in adjusted models (hazard ratio, 1.18). In subgroups with controlled dyslipidemia and diabetes, the association was attenuated; however, it remained elevated for PWH with controlled hypertension or higher total cholesterol. The subgroup with frequent unhealthy alcohol use had the strongest HIV status association with CVD (hazard ratio, 2.13).

"While effective control of dyslipidemia and diabetes may help reduce the CVD disparity in PWH, elevated CVD risks are concerning despite well-controlled hypertension," the authors write.

Two authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords